KR880007553A - 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 - Google Patents

항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 Download PDF

Info

Publication number
KR880007553A
KR880007553A KR870014349A KR870014349A KR880007553A KR 880007553 A KR880007553 A KR 880007553A KR 870014349 A KR870014349 A KR 870014349A KR 870014349 A KR870014349 A KR 870014349A KR 880007553 A KR880007553 A KR 880007553A
Authority
KR
South Korea
Prior art keywords
urea
nrrl
streptomyces
complex
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR870014349A
Other languages
English (en)
Korean (ko)
Inventor
드와인 뵉크 라베른
마틴 훼혼 마빈
앤드류 커스트 허베르트
헤인즈 미첼 카알
토마스 세노 유진
쥬니어 오티스 웨브스터 가드프레이
Original Assignee
마리 앤 터커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마리 앤 터커, 일라이 릴리 앤드 캄파니 filed Critical 마리 앤 터커
Publication of KR880007553A publication Critical patent/KR880007553A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR870014349A 1986-12-15 1987-12-15 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 Ceased KR880007553A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94189486A 1986-12-15 1986-12-15
US94147386A 1986-12-15 1986-12-15
US941473 1986-12-15
US941894 1986-12-15

Publications (1)

Publication Number Publication Date
KR880007553A true KR880007553A (ko) 1988-08-27

Family

ID=27130157

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870014349A Ceased KR880007553A (ko) 1986-12-15 1987-12-15 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법

Country Status (15)

Country Link
EP (1) EP0274873B1 (enExample)
JP (1) JPS63258585A (enExample)
KR (1) KR880007553A (enExample)
CN (1) CN1023758C (enExample)
AU (1) AU604806B2 (enExample)
DE (1) DE3781878T2 (enExample)
DK (1) DK654987A (enExample)
ES (1) ES2052584T3 (enExample)
GR (1) GR3006408T3 (enExample)
HU (1) HU199559B (enExample)
IE (1) IE60394B1 (enExample)
IL (1) IL84819A (enExample)
MX (1) MX170925B (enExample)
NZ (1) NZ222895A (enExample)
PT (1) PT86364B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25145A (en) * 1986-12-15 1991-02-19 Laverne Dwaine Boeck Process for producing the a10255 complex and corresponding microorganism
US5229362A (en) * 1986-12-15 1993-07-20 Eli Lilly And Company Antibiotic A10255 complex and factors, and process and production therefor
DE3851268T2 (de) * 1987-06-19 1995-01-26 Sandoz Ag Zyklische Peptolide.
IT1234197B (it) * 1988-06-14 1992-05-06 Mini Ricerca Scient Tecnolog Antibiotici ottenuti mediante coltivazione aerobica controllata dello streptomyces s.p. ncib 12629
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
SI1413331T1 (sl) 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
JP4711600B2 (ja) 2001-01-26 2011-06-29 シェーリング コーポレイション シトステロール血症の処置のための置換アゼチジノン化合物の使用
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7132415B2 (en) 2001-09-21 2006-11-07 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
CA2504878A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CA2513793A1 (en) 2003-02-18 2004-09-02 Incro Limited Dispenser pump
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
BR112012004643A2 (pt) * 2009-09-02 2019-09-24 Piramal Life Scinces Ltd compostos antibióticos

Also Published As

Publication number Publication date
EP0274873A3 (en) 1989-08-09
CN87108341A (zh) 1988-08-10
IE60394B1 (en) 1994-07-13
PT86364A (en) 1988-01-01
MX170925B (es) 1993-09-22
EP0274873A2 (en) 1988-07-20
DE3781878T2 (de) 1993-03-11
HU199559B (en) 1990-02-28
IE873390L (en) 1988-06-15
EP0274873B1 (en) 1992-09-23
CN1023758C (zh) 1994-02-16
DE3781878D1 (de) 1992-10-29
IL84819A (en) 1993-07-08
HUT49376A (en) 1989-09-28
JPS63258585A (ja) 1988-10-26
NZ222895A (en) 1992-08-26
GR3006408T3 (enExample) 1993-06-21
ES2052584T3 (es) 1994-07-16
PT86364B (pt) 1990-11-07
AU8249387A (en) 1988-07-28
DK654987D0 (da) 1987-12-14
DK654987A (da) 1988-09-23
AU604806B2 (en) 1991-01-03

Similar Documents

Publication Publication Date Title
KR880007553A (ko) 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법
Yasumoto et al. New tetrodotoxin analogs from the newt Cynops ensicauda
JPH0574595B2 (enExample)
DE2754326C2 (de) Antibiotikum AM 2282, seine Herstellung und Arzneimittel
GB985598A (en) Improvements in or relating to antibiotics and their preparation
US4416899A (en) Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient
KR840004168A (ko) A41030 항생물질의 제조방법
KR890002418A (ko) Ab-006 항생물질 및 그의 제조방법
DE3683860D1 (de) Verbindung cl-1577-b4, ihre herstellung und verwendung.
FI914477A0 (fi) Mikrobiologiskt foerfarande foer framstaellning av hydroxylerade heterocykliska foereningar.
KR840008817A (ko) Bbm-1675, 새로운 항암 항생복합체
HARA et al. DC 102, a new glycosidic pyrrolo (1, 4) benzodiazepine antibiotic produced by Streptomyces sp.
JPS62234040A (ja) Ｄｃ１０４３物質
ISSHIKI et al. A new antibiotic indisocin and N-methylindisocin
KR910014398A (ko) 항생제 데옥시물룬도칸딘, 이의 제조방법 및 약제로서의 이의 용도
DE2645528C3 (de) Antibiotisch wirksame Pyrrole [2,1c] -1,4benzdiazepine
TYMIAK et al. Oxazinomycin produced by a Pseudomonas species
RU2001102052A (ru) Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата
US3769403A (en) Ericamycin and production thereof
GB1500847A (en) Antibiotic a process for its preparation and its use as a medicament
US4209509A (en) Substance SF-1739 derivatives, process for preparing the same and antibacterial compositions containing the same
JPH05271215A (ja) 新規なポリエンマクロライド化合物及びそれを有効成分とする抗真菌剤
Imagawa et al. Isolation and Structure Elucidation of I-851, an Antagonist of Chloramphenicol
GB1494449A (en) Ionomycin
US3808331A (en) Tetrahexin and process for preparing same

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19871215

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19920825

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19871215

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19960320

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19960528

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19960320

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I